Ikarian Capital’s Intellia Therapeutics NTLA Stock Holding History

Ikarian Capital’s Portfolio NTLA Stock Details NTLA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell
2022 Q1	$3.44M	Buy
2021 Q3	–	Hold
2021 Q2	–	Hold
2020 Q2	–	Sell
2020 Q1	$2.26M	Buy